| |
|
|
|
Evelo Biosciences Inc  
|
|
4.8157 0.356 (0.08%) |
10-20 15:39 |
|
Open: |
4.57 |
Pre close: |
4.46 |
Target:
|
6.23
|
|
High: |
4.82 |
Low: |
4.405 |
Resistance:
|
5.33
6.15
|
|
Volume: |
85,174 |
Market Cap: |
222M |
Support:
|
4.01
3.34
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.87
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
5.05  |
Signal(12,26,9): |
0.11 |
|
MA(100): |
4.56 |
Stochastic Oscillator |
%K(14,3):
|
15.24 |
|
MA(250): |
4.74 |
%D(3): |
22.06 |
|
Average Volume(K) |
3-Month: |
16772
|
52-Week |
High:
|
8.30 |
|
10-Days: |
18139 |
Low: |
3.01 |
|
RSI |
RSI(14):
|
45.58 |
Change(%): |
-36.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.720 |
Return on Equity (ttm) |
-103.9 |
Shares Out. (M) |
46.14 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-45.6 |
Shares Float (M) |
19.94 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.13 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
86.57 |
|
Forward EPS |
-2.780 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1450 |
|
Book Value (p.s.) |
1.500 |
EBITDA (p.s.) |
-1.857 |
P/E |
-1.74 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.15 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-74.52 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-44.73 |
P/CF |
-2.92 |
|
|
|
|
|
|
